HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation
TSX-V:HME • CA4236301020
Current stock price
2.98 CAD
+0.01 (+0.34%)
Last:
This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HME.CA Profitability Analysis
1.1 Basic Checks
- HME had positive earnings in the past year.
- HME had a positive operating cash flow in the past year.
- HME had positive earnings in each of the past 5 years.
- HME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of HME (23.12%) is better than 98.03% of its industry peers.
- The Return On Equity of HME (34.75%) is better than 98.52% of its industry peers.
- HME has a better Return On Invested Capital (29.46%) than 99.01% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for HME is significantly above the industry average of 6.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROIC | 29.46% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
1.3 Margins
- Looking at the Profit Margin, with a value of 29.84%, HME belongs to the top of the industry, outperforming 94.58% of the companies in the same industry.
- HME's Profit Margin has improved in the last couple of years.
- HME has a Operating Margin of 42.20%. This is amongst the best in the industry. HME outperforms 92.61% of its industry peers.
- HME's Operating Margin has improved in the last couple of years.
- With a decent Gross Margin value of 60.69%, HME is doing good in the industry, outperforming 77.83% of the companies in the same industry.
- HME's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% |
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
2. HME.CA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HME is creating value.
- The number of shares outstanding for HME has been reduced compared to 1 year ago.
- The number of shares outstanding for HME has been increased compared to 5 years ago.
- The debt/assets ratio for HME has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 6.34 indicates that HME is not in any danger for bankruptcy at the moment.
- HME has a Altman-Z score of 6.34. This is amongst the best in the industry. HME outperforms 85.71% of its industry peers.
- The Debt to FCF ratio of HME is 0.09, which is an excellent value as it means it would take HME, only 0.09 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.09, HME belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
- HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.03, HME is in the better half of the industry, outperforming 76.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Altman-Z | 6.34 |
ROIC/WACC3.67
WACC8.03%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
- HME has a better Current ratio (1.37) than 69.46% of its industry peers.
- A Quick Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
- The Quick ratio of HME (1.37) is better than 70.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. HME.CA Growth Analysis
3.1 Past
- The earnings per share for HME have decreased strongly by -15.15% in the last year.
- Measured over the past years, HME shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.83% on average per year.
- HME shows a decrease in Revenue. In the last year, the revenue decreased by -6.07%.
- HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.14% yearly.
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
3.2 Future
- The Earnings Per Share is expected to decrease by -16.11% on average over the next years. This is quite bad
- HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.33% yearly.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. HME.CA Valuation Analysis
4.1 Price/Earnings Ratio
- HME is valuated reasonably with a Price/Earnings ratio of 10.64.
- Based on the Price/Earnings ratio, HME is valued a bit cheaper than 75.86% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.51, HME is valued rather cheaply.
- With a Price/Forward Earnings ratio of 11.57, the valuation of HME can be described as very reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HME indicates a somewhat cheap valuation: HME is cheaper than 74.38% of the companies listed in the same industry.
- HME is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.41, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 11.57 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaper than 90.64% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, HME is valued cheaper than 91.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.81 | ||
| EV/EBITDA | 5.17 |
4.3 Compensation for Growth
- The excellent profitability rating of HME may justify a higher PE ratio.
- HME's earnings are expected to decrease with -16.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
5. HME.CA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.37%, HME has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 3.89, HME pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.80, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.37% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- HME pays out 54.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP54.76%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:HME (5/1/2026, 7:00:00 PM)
2.98
+0.01 (+0.34%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Industry Strength87.5
Industry Growth40.3
Earnings (Last)04-15 2026-04-15/bmo
Earnings (Next)05-20 2026-05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap281.01M
Revenue(TTM)93.86M
Net Income(TTM)28.01M
Analysts84.44
Price Target2.96 (-0.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.37% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP54.76%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14 2026-05-14 (0.03)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11%
Min EPS beat(2)-19.09%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-19.09%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.2%
EPS beat(12)4
Avg EPS beat(12)-3.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-0.21%
Revenue beat(4)2
Avg Revenue beat(4)1.55%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 11.57 | ||
| P/S | 2.99 | ||
| P/FCF | 8.81 | ||
| P/OCF | 5.83 | ||
| P/B | 3.49 | ||
| P/tB | 3.49 | ||
| EV/EBITDA | 5.17 |
EPS(TTM)0.28
EY9.4%
EPS(NY)0.26
Fwd EY8.64%
FCF(TTM)0.34
FCFY11.35%
OCF(TTM)0.51
OCFY17.14%
SpS1
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.32039 (-22.13%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROCE | 39.28% | ||
| ROIC | 29.46% | ||
| ROICexc | 36.52% | ||
| ROICexgc | 36.52% | ||
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% | ||
| FCFM | 33.99% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
ROICexc(3y)37.5%
ROICexc(5y)37.01%
ROICexgc(3y)37.5%
ROICexgc(5y)37.01%
ROCE(3y)43.29%
ROCE(5y)45.29%
ROICexgc growth 3Y-7.82%
ROICexgc growth 5Y43.82%
ROICexc growth 3Y-7.82%
ROICexc growth 5Y43.82%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 140.25% | ||
| Cap/Sales | 17.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.07% | ||
| Profit Quality | 113.94% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 6.34 |
F-Score6
WACC8.03%
ROIC/WACC3.67
Cap/Depr(3y)180.21%
Cap/Depr(5y)207.89%
Cap/Sales(3y)19.72%
Cap/Sales(5y)21.17%
Profit Quality(3y)100.55%
Profit Quality(5y)107.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-11.49%
EBIT growth 3Y-3.12%
EBIT growth 5Y58.75%
EBIT Next Year28.61%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y29.21%
FCF growth 3Y5.96%
FCF growth 5Y32.87%
OCF growth 1Y3.47%
OCF growth 3Y2.22%
OCF growth 5Y38.68%
HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
What is the profitability of HME stock?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
Can you provide the financial health for HME stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
What is the earnings growth outlook for HEMISPHERE ENERGY CORP?
The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.